Technology

AI-powered precision for
next-generation therapeutics

Decode protein dynamics to unlock undruggable targets—advancing therapies that go beyond treatment to true transformation.

  • Pattern Recognition
  • GlueHunter 1.0
  • LeadHunter 2.0
  • ERST-LAB
Pattern Recognition
AI Technology

ERSTEQ’s pattern recognition platform deciphers structural and dynamic signatures—analyzing surface complementarity, conformational shifts, and dynamic binding interfaces—to predict biologically relevant interactions and unlock undruggable targets.

Proprietary pattern recognition technology optimized for the evolving landscape of novel therapeutic modalities

GlueHunter 1.0

AI-Powered Rational Molecular Glue Discovery Platform

GlueHunter1.0 integrates two specialized engines that accelerate the discovery Neo-degradable targets and molecular glues/PPI modulators through complementary pattern recognition analysis

  1. 1Neo-substrate Identification

    Analyzes surface interactions, target recruitment and anchoring factors, and structural complementarity to identify novel neo-substrates with high therapeutic potential.
  2. 2Molecular Glue Discovery

    Extracts geometric and topological features, maps 3D conformational changes, and profiles dynamic binding interfaces to enable the rational design of tailored molecular glues.

Applications
Enables the end-to-end discovery of molecular glue degraders and stabilizers, the identification of novel neo-substrates, and the design of PPI modulators to precisely regulate protein–protein interactions, driving therapeutic innovation across oncology, neurodegeneration, and other disease areas.

LeadHunter 2.0

Target-centric, Motion & Motility-driven Drug Discovery Platform

LeadHunter 2.0 analyzes therapeutically actionable patterns through atomic-level assessment of three-dimensional structural data, powered by the dynamic conformational changes of target proteins.
This approach goes beyond static models to reveal hidden opportunities for drug intervention.

  1. 1Hot Spot Identification

    Evaluates binding affinity, functional and disease-associated mechanisms, and structural complementarity to pinpoint functionally relevant binding sites with high druggability.
  2. 2Motion & Motility Analysis

    Profiles geometric and topological features, captures 3D conformational changes, and maps dynamic binding interfaces to uncover previously inaccessible regulatory sites.

Applications
Enables the discovery of small molecule regulators—including inhibitors and activators—designed to precisely modulate target protein function.

ERST- LAB

Full-cycle (end-to-end, from in silico to in vivo) validation is delivered from molecule to animal, with real-time feedback integrated into the AI drug discovery platform—powering smarter, faster drug discovery. In addition, the validation system provides target-specific, high-precision efficacy assessment to support confident decision-making in drug development.

Rapid, Continuously improving of Drug discovery